NEW LIFE
0772.650.134 · rovalta.com · 24/09/2026
NEW LIFE
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBONEW LIFE is a Private limited company incorporated in 2021. Its registered office is in Leuven.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0772.650.134
- Incorporation
- 29/07/2021
- Legal form
- Private limited company
- Registered office
- Schipvaartstraat 4
3000 Leuven · FlandreSee on map - Contributed capital
- 10 820,41 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 4 filingsTrend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 1,1 k € | -88.3% | 9,2 k € | +87.5% | 4,9 k € | -87.0% | 37,6 k € |
| EBITDA | 1,1 k € | -88.3% | 9,2 k € | +87.5% | 4,9 k € | -87.0% | 37,6 k € |
| Operating result | 1,1 k € | -88.3% | 9,2 k € | +87.5% | 4,9 k € | -87.0% | 37,6 k € |
| Net result | -174,4 € | -103% | 6 k € | +128% | 2,6 k € | -90.3% | 27,3 k € |
| Balance sheet | |||||||
| Equity | 151,7 k € | -0.1% | 151,8 k € | +4.1% | 145,8 k € | +1.8% | 143,2 k € |
| Total assets | 337,2 k € | +24.7% | 270,4 k € | +4.3% | 259,1 k € | -47.5% | 493,4 k € |
| Cash | 141,3 k € | -5.7% | 149,8 k € | -3.5% | 155,3 k € | -42.9% | 272,1 k € |
| Debts | 6,7 k € | -20.9% | 8,5 k € | -42.8% | 14,9 k € | +192% | 5,1 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/2025Other companies at this address
Schipvaartstraat 4 3000 Leuven| Company | CBE no. |
|---|---|
| 0871.008.233 | |
| 0440.752.063 | |
LIFE EXPERT CENTRE● Active | 0641.784.959 |
Life Leuven● Active | 0666.668.528 |
LIFE LEUVEN INVEST● Active | 0846.088.636 |
Maatschap CV LEC● Active | 0783.567.483 |
NEW OFIR● Active | 0449.037.348 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 18/08/2021 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 17 months |
| Filing date | 22/06/2026 | 06/06/2025 | 02/07/2024 | 26/06/2023 |
| General meeting | 29/05/2026 | 30/05/2025 | 31/05/2024 | 26/05/2023 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 4 filingsValuation
Indicative valuation
As an indication, this company is worth
between 100 k€ and 250 k€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2025Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring25/08/2021RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-174,4 €↓
- 2024Annual accounts 20246 k €↑
- 2023Annual accounts 20232,6 k €↓
- 2022Annual accounts 202227,3 k €
- 29/07/2021IncorporationPrivate limited company